Delta Health Care S.R.L.

At Delta Health Care S.R.L. in Bucharest, this research area focuses on cardiovascular diseases and metabolic disorders, including hypertension, acute myocardial infarction, stable angina, elevated lipoprotein(a), and broader atherosclerotic risk. The trials are designed to assess new treatments that may improve heart and vascular outcomes, lower blood pressure, and reduce long-term cardiovascular events.

• Hypertension and uncontrolled blood pressure management
• Acute myocardial infarction and recurrent heart-risk prevention
• Stable angina pectoris symptom control
• Atherosclerotic cardiovascular disease and elevated Lp(a) risk reduction

The studies in this field mainly evaluate whether new therapies can improve cardiovascular protection, support blood-pressure control, and help prevent serious complications.

This site conducts extensive research in digestive system diseases, especially Crohn’s disease and ulcerative colitis. The trials are centered on testing innovative therapies aimed at reducing inflammation, improving symptom control, and helping patients achieve or maintain remission.

• Crohn’s disease across active and long-term treatment settings
• Ulcerative colitis in adults and adolescents
• Evaluation of treatments for moderately to severely active inflammatory bowel disease
• Studies of therapy effectiveness, remission, and maintenance of response

Several studies also explore how patients experience treatment in everyday life, adding a patient-centered view to the clinical results.

Another major focus is immune system diseases, with research in systemic lupus erythematosus, rheumatoid arthritis, psoriatic arthritis, and primary Sjögren’s disease. These trials aim to better control disease activity, reduce flare burden, and evaluate longer-term safety and effectiveness of emerging therapies.

• Systemic lupus erythematosus and cutaneous lupus-related conditions
• Rheumatoid arthritis and psoriatic arthritis
• Primary Sjögren’s disease with systemic symptom assessment
• Testing therapies that may reduce immune-driven inflammation and improve daily functioning

The work in this area reflects a strong interest in improving treatment options for complex chronic autoimmune diseases.

As a Urology department, this site also supports research in female urogenital diseases and genitourinary cancers. Trials include high-risk non-muscle-invasive bladder cancer, low-grade upper tract urothelial cancer, metastatic castration-resistant prostate cancer, and urinary incontinence, with a focus on better disease control and improved quality of life.

• Bladder cancer and upper tract urothelial cancer
• Prostate cancer in advanced or metastatic settings
• Urinary incontinence in women
• Studies evaluating new treatment options and better symptom management

These trials combine cancer-focused research with practical efforts to address urinary symptoms that affect everyday comfort and function.

The site is active in respiratory tract diseases and otorhinolaryngologic diseases, including asthma, chronic rhinosinusitis with nasal polyps, and birch pollen-induced allergic rhinoconjunctivitis. Research here aims to improve breathing, reduce nasal and airway inflammation, and test therapies that may offer better day-to-day control.

• Moderate to severe asthma and uncontrolled asthma
• Chronic rhinosinusitis with nasal polyps
• Allergic rhinoconjunctivitis caused by birch pollen
• Evaluation of treatments intended to ease symptoms and improve respiratory function

These studies address both chronic airway disease and seasonal allergy-related conditions, with an emphasis on meaningful symptom relief.

Clinical trials at this site also cover hormonal diseases and nutritional and metabolic diseases, including acromegaly and metabolic dysfunction-associated steatotic liver disease. The goal is to evaluate therapies that can better regulate hormone-related disease activity and address metabolic complications.

• Acromegaly and hormone-related control
• Metabolic dysfunction-associated steatotic liver disease
• Assessment of treatments for reducing disease burden and improving metabolic outcomes
• Research into longer-term disease management in chronic endocrine conditions

This portfolio shows interest in conditions where metabolic balance and hormone regulation play a central role in patient health.

The oncology portfolio includes trials in neoplasms such as non-small cell lung cancer, metastatic breast cancer, and colorectal cancer. These studies are aimed at comparing new treatment strategies, improving survival outcomes, and identifying more effective options for patients with advanced disease.

• Non-small cell lung cancer, including advanced and resectable disease
• Breast cancer with metastatic or hormone-responsive disease
• Colorectal cancer with recurrent or metastatic disease
• Trials focused on treatment effectiveness and disease control

Research in this area reflects the site’s involvement in testing new cancer therapies across several major solid tumor types.

Delta Health Care S.R.L. also participates in trials spanning skin and connective tissue diseases and broader physiological processes, including endometriosis-related pain and stress urinary incontinence. These studies aim to improve symptom relief, daily functioning, and patient well-being in conditions that can significantly affect quality of life.

• Endometriosis-related pain
• Stress urinary incontinence
• Evaluation of therapies for symptom reduction and improved comfort
• Research with a strong focus on everyday impact and patient experience

Although smaller in scope than the major disease areas, these studies add important breadth to the site’s clinical research activity.